エピソード

  • Shelby Clark: Turo

    Shelby Clark: Turo
    2025/05/24
    In this episode, Joel Palathinkal engages with Shelby Clark, delving into his innovative journey with Turo and the challenges and growth the company has experienced. Shelby shares his personal journey in mental health and therapy, discussing the importance of risk management, insurance, and regulatory challenges faced by Turo. The conversation shifts to adaptability and handling entrepreneurial curveballs, exploring tax benefits and the hurdles of innovation. Shelby's transition to investing with a focus on mental health is discussed, along with emerging technologies such as neurotech and the microbiome. The episode concludes with Shelby's closing remarks and outlook for the future.
    続きを読む 一部表示
    39 分
  • Robert B. Weiss: Kramer Levin

    Robert B. Weiss: Kramer Levin
    2025/05/23
    In this episode, the focus is on the critical role of legal counsel in fund formation, featuring Robert B. Weiss from Kramer Levin an expert guest discussing the "anatomy of fund documents." The conversation begins with an overview of private fund formation and essential fund characteristics. Topics include the indicative closing checklist, custodian use, LLC agreement structure, and marketing presentations for funds. The episode delves into side letters, their applications, economic terms, and most favored nation provisions. Offshore investment tax considerations and side letter expenses are also explored. Listeners gain insight into fund entity setup, initial documents, and fund manager insurance, with a look ahead to future sessions and a Q&A segment.
    続きを読む 一部表示
    49 分
  • Krista Morgan: Stage Fund

    Krista Morgan: Stage Fund
    2025/05/22
    In this episode, Joel Palathinkal chats with Krista Morgan about her transition from private equity to launching Stage Fund. They discuss the challenges of starting the fund, the role of family dynamics in business, and Stage Fund's acquisition and restructuring strategy, highlighted by a retail tech case study. The conversation covers founders' roles post-acquisition, creative deal structures, and asset disposition strategies. They also explore roll-ups in private equity, control investments, and leveraging platforms for deal sourcing. Krista shares insights on engaging Limited Partners, syndicating with high-net-worth individuals, and future fund structure trends.
    続きを読む 一部表示
    50 分
  • Victor Kwok: Stealth AI Company

    Victor Kwok: Stealth AI Company
    2025/05/20
    Join Joel Palathinkal and Victor Kwok as they explore Victor's journey in founding VantagePoint and his AI investment thesis. They discuss AI's potential to disrupt industries, legal risks for CFOs, and finance considerations for startups. The episode covers insurance essentials, co-founder dynamics, and crafting strong investment theses. Delve into AI applications in healthcare, focusing on predictive analysis and at-home testing, and discuss the evolution of AI-human interaction, healthcare innovation challenges, and ethical considerations. Joel and Victor conclude with AI's role in futuristic concepts and key takeaways from their conversation.
    続きを読む 一部表示
    43 分
  • Akira Dunham: Fundomo

    Akira Dunham: Fundomo
    2025/05/19
    Joel Palathinkal sits down with Akira Dunham from Fundomo to discuss her multicultural journey into venture capital and her roles at Hillside Ventures and Connecticut Innovations. They explore Connecticut Innovations' commitment to diverse founders and the evergreen fund, along with their international investment strategies in Israel and Toronto. The conversation delves into the tech ecosystem in Connecticut, focusing on Climate Haven, New Haven's biotech scene, and quantum computing initiatives. They also cover future trends in AI, energy, and human-computer interfaces, as well as innovations in urban planning and mobility. Akira shares advice on entering venture capital and discusses career opportunities in India, Canada, and Israel.
    続きを読む 一部表示
    47 分
  • Olaf Sakkers: RedBlue Capital

    Olaf Sakkers: RedBlue Capital
    2025/05/18
    Joel Palathinkal talks to Olaf Sakkers about the future of electric vehicles and transportation. Olaf shares insights on mobility startups, especially in South Africa's tech scene, and discusses challenges for Japanese carmakers. They explore strategies for evaluating startups, due diligence, and networking for fund managers. The episode highlights relationship-building with Limited Partners (LPs), co-investment strategies, and creative LP engagement. It wraps up with thoughts on trust, communication, and enjoying work, with a mention of NVIDIA's founder.
    続きを読む 一部表示
    54 分
  • Anton Belyakov: Flashpoint Ventures and AI in VC

    Anton Belyakov: Flashpoint Ventures and AI in VC
    2025/05/17
    Joel Palathinkal engages with Anton to discuss his transition from physics to finance and his journey in venture capital. Anton elaborates on his investment strategy with a global perspective, distinguishing between prop desk and typical trading desk operations. The episode delves into portfolio management tactics and contrasts business management with scientific experimentation. Anton shares insights on trends in private equity and highlights Flashpoint's AI-focused investment approach. They explore social responsibility in B2B software evaluation and how to discern true AI innovation. The conversation touches on AI applications in niche markets, founder-product fit, and offers guidance for fund managers, emphasizing the importance of perpetual learning.
    続きを読む 一部表示
    36 分
  • Nathan Lian: Pareto VC

    Nathan Lian: Pareto VC
    2025/05/16
    Joel Palathinkal explores the intersection of AI and biotech with Nathan Lian from Pareto VC. Nathan discusses his career journey and investment strategies in deep tech and biotech. They delve into AI's role in drug discovery, lab experiments, and the PH fellowship's goals and selection process. The conversation highlights opportunities in synthetic biology, longevity, health tech, and behavioral psychology. They also address challenges in real-time health data and continuous monitoring, emphasizing user experience in health predictive analytics. This episode offers a comprehensive look at the future of biotech investments.
    続きを読む 一部表示
    38 分